Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Operational and Clinical Strategies to Address Drug Cost Containment in the Acute Care Setting.

McConnell KJ, Guzman OE, Pherwani N, Spencer DD, Van Cura JD, Shea KM.

Pharmacotherapy. 2016 Oct 27. doi: 10.1002/phar.1858. [Epub ahead of print]

PMID:
27785827
2.

Clinical pathways in chronic lymphocytic leukemia: Challenges and solutions.

Nabhan C, Mato AR, Feinberg BA.

Am J Hematol. 2016 Oct 20. doi: 10.1002/ajh.24589. [Epub ahead of print] No abstract available.

PMID:
27766676
3.

A One Health overview, facilitating advances in comparative medicine and translational research.

Stroud C, Dmitriev I, Kashentseva E, Bryan JN, Curiel DT, Rindt H, Reinero C, Henry CJ, Bergman PJ, Mason NJ, Gnanandarajah JS, Engiles JB, Gray F, Laughlin D, Gaurnier-Hausser A, Wallecha A, Huebner M, Paterson Y, O'Connor D, Treml LS, Stannard JP, Cook JL, Jacobs M, Wyckoff GJ, Likins L, Sabbagh U, Skaff A, Guloy AS, Hays HD, LeBlanc AK, Coates JR, Katz ML, Lyons LA, Johnson GC, Johnson GS, O'Brien DP, Duan D, Calvet JP, Gandolfi B, Baron DA, Weiss ML, Webster DA, Karanu FN, Robb EJ, Harman RJ.

Clin Transl Med. 2016 Aug;5(Suppl 1):26. doi: 10.1186/s40169-016-0107-4.

4.

A Synchronized Prescription Refill Program Improved Medication Adherence.

Doshi JA, Lim R, Li P, Young PP, Lawnicki VF, State JJ, Troxel AB, Volpp KG.

Health Aff (Millwood). 2016 Aug 1;35(8):1504-12. doi: 10.1377/hlthaff.2015.1456.

PMID:
27503977
5.

ASHP Statement on the Roles of Pharmacy Technicians.

Schultz JM, Jeter CK, Martin NM, Mundy TK, Reichard JS, Van Cura JD.

Am J Health Syst Pharm. 2016 Jun 15;73(12):928-30. doi: 10.2146/ajhp151014. No abstract available.

PMID:
27261243
6.

Are first-generation cephalosporins obsolete? A retrospective, non-inferiority, cohort study comparing empirical therapy with cefazolin versus ceftriaxone for acute pyelonephritis in hospitalized patients.

Hobbs AL, Shea KM, Daley MJ, Huth RG, Jaso TC, Bissett J, Hemmige V.

J Antimicrob Chemother. 2016 Jun;71(6):1665-71. doi: 10.1093/jac/dkw035.

PMID:
26983859
7.

WHS guidelines update: Diabetic foot ulcer treatment guidelines.

Lavery LA, Davis KE, Berriman SJ, Braun L, Nichols A, Kim PJ, Margolis D, Peters EJ, Attinger C.

Wound Repair Regen. 2016 Jan-Feb;24(1):112-26. doi: 10.1111/wrr.12391. No abstract available.

PMID:
26663430
8.

Implications of Augmented Renal Clearance on Drug Dosing in Critically Ill Patients: A Focus on Antibiotics.

Hobbs AL, Shea KM, Roberts KM, Daley MJ.

Pharmacotherapy. 2015 Nov;35(11):1063-75. doi: 10.1002/phar.1653. Review.

PMID:
26598098
9.

Cost-Effectiveness and Cost-Utility Analyses Comparing Strategies for Initial Treatment of Rheumatoid Arthritis Using Published Outcomes: Economic Lessons From The Tear Trial.

Fuchs PA, Lal L, Fuchs HA, Swint J.

Value Health. 2015 Nov;18(7):A671. doi: 10.1016/j.jval.2015.09.2454. No abstract available.

10.

Analysis of Eribulin Mesylate Utilzation in Patients with Metastatic Breast Cancer (Mbc) by Line of Therapy and Associated Changes Over Time.

Feinberg BA, Drenning J, Garofalo DF, Montgomery J.

Value Health. 2015 Nov;18(7):A479-80. doi: 10.1016/j.jval.2015.09.1299. No abstract available.

11.

Insurance Plan Switch Patterns Among Breast Cancer Patients Compared to Non-Cancer Patients.

Feinberg BA, Drenning J, Garofalo DF, Lal L.

Value Health. 2015 Nov;18(7):A476. doi: 10.1016/j.jval.2015.09.1276. No abstract available.

12.

Evaluation Of Resource Utilizaton For Chemotherapy Induced Nausea And Vomiting (Cinv) In Patients Treated With Anthracycline+Cyclophosphamide (Ac) For Solid Cancers With And Without Nk-1 Based Regimens.

Lyman GH, Lal L, Radtchenko J, Harrow B, Schwartzberg L.

Value Health. 2015 Nov;18(7):A465. doi: 10.1016/j.jval.2015.09.1218. No abstract available.

13.

Analysis Of Eribulin Mesylate Dosing Modifications Impact On Administration Persistence In Patients With Metastatic Breast Cancer (Mbc).

Feinberg BA, Drenning J, Garofalo DF, Lal L, Montgomery J.

Value Health. 2015 Nov;18(7):A434. doi: 10.1016/j.jval.2015.09.1043. No abstract available.

14.

Evaluation Of Patterns Of Care In Renal Cell Carcinoma (Rcc): High Unmet Need Persists.

Feinberg BA, Bohr M, Drenning J, Garofalo DF, Montgomery J.

Value Health. 2015 Nov;18(7):A432-3. doi: 10.1016/j.jval.2015.09.1035. No abstract available.

15.

Comparison Of Treatment Duration Among Targeted Agents In Renal Cell Carcinoma (Rcc).

Feinberg BA, Bohr M, Drenning J, Garofalo DF, Montgomery J.

Value Health. 2015 Nov;18(7):A432. doi: 10.1016/j.jval.2015.09.1034. No abstract available.

16.

Resource Utilization for Chemotherapy-Induced Nausea and Vomiting Events in Patients with Solid Tumors Treated with Antiemetic Regimens.

Schwartzberg L, Harrow B, Lal LS, Radtchenko J, Lyman GH.

Am Health Drug Benefits. 2015 Jul-Aug;8(5):273-82.

17.

Significant publications on infectious diseases pharmacotherapy in 2014.

Phe K, Cadle RM, Guervil DJ, Guzman OE, Lockwood AM, Perez KK, Vuong NN, Aitken SL; Houston Infectious Diseases Network..

Am J Health Syst Pharm. 2015 Aug 15;72(16):1380-92. doi: 10.2146/ajhp150112.

PMID:
26246295
18.

Outpatient management of febrile neutropenia associated with cancer chemotherapy: risk stratification and treatment review.

Pherwani N, Ghayad JM, Holle LM, Karpiuk EL.

Am J Health Syst Pharm. 2015 Apr 15;72(8):619-31. doi: 10.2146/ajhp140194. Review.

PMID:
25825185
19.

Support for "second victims".

Nicol N.

Am J Health Syst Pharm. 2015 Apr 1;72(7):523. doi: 10.2146/ajhp150131. No abstract available.

PMID:
25788505
20.

Significant publications on infectious diseases pharmacotherapy in 2013.

Hunter AS, Guervil DJ, Perez KK, Schilling AN, Verheyden CN, Vuong NN, Xu R; Houston Infectious Diseases Network..

Am J Health Syst Pharm. 2014 Nov 15;71(22):1974-88. doi: 10.2146/ajhp140148.

PMID:
25349243
Items per page

Supplemental Content

Loading ...
Support Center